Stand-on Ride-on Power Mobility Devices for Children With Cerebral Palsy
This study is looking at how using a special stand-on ride-on power mobility device (PMD) affects children with cerebral palsy. We want to understand how these devices help improve balance and movement. Children aged 4 to 6 years old with spastic diplegia cerebral palsy (GMFCS level III) who can stand and walk short distances are eligible. If you join, your child will use an individually-adapted stand-on PMD at home for three months. We will measure their balance and ability to move before and after using the device to see if it helps. The study aims to enroll 10 children, but the current recruitment status is unclear.
- Study design
- This is an interventional study involving 10 participants. It is not specified if it is randomized or blinded.
- What's involved
- Your child would use an individually-adapted stand-on PMD at home for three months. They will have tests to measure balance and mobility at the start, after three months, and again three months later.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will be followed for three months after the intervention period.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Stand-on Ride-on Power Mobility Devices for Children With Cerebral Palsy
At a glance
Conditions
Where it's being run
1 sites across 1 statesWho to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
What this trial measures
- Center of Pressure Sway Area, StandingPre (immediately before intervention), Post (3 months post Pre)
Center of pressure sway area during quiet standing was quantified as the 95% confidence ellipse area derived from force plate measurements. Larger sway area values indicate greater postural sway and reduced standing balance stability. Reported values represent the absolute measurements obtained during each of the pre-intervention and post-intervention assessments. For participants completing multiple standing trials at an assessment, the participant-level median across trials was used for analysis. The reported values represent the group median of the participant-level medians for the pre-intervention and post-intervention assessments.